▶ 調査レポート

世界のmRNAワクチン&治療薬産業2020-2026

• 英文タイトル:Global mRNA Vaccines & Therapeutics Industry Research Report, Growth Trends and Competitive Analysis 2020-2026

QYResearchが調査・発行した産業分析レポートです。世界のmRNAワクチン&治療薬産業2020-2026 / Global mRNA Vaccines & Therapeutics Industry Research Report, Growth Trends and Competitive Analysis 2020-2026 / D0MA3012417資料のイメージです。• レポートコード:D0MA3012417
• 出版社/出版日:QYResearch / 2020年1月
• レポート形態:英文、PDF、116ページ
• 納品方法:Eメール(納期:2~3日)
• 産業分類:製薬・医療
• 販売価格(消費税別)
  Single User¥539,000 (USD4,900)▷ お問い合わせ
  Multi User¥808,500 (USD7,350)▷ お問い合わせ
  Enterprise License¥1,078,000 (USD9,800)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
当リサーチレポートでは、mRNAワクチン&治療薬の世界市場規模が2019年xx百万ドルから2026年xx百万ドルまで年平均xx%成長すると予測しています。当レポートは、mRNAワクチン&治療薬のグローバル市場動向、メーカー別競争状況、種類別市場規模(がん治療標準化MRNAワクチン、個別がん治療MRNAワクチン、感染症治療MRNAワクチン、感染予防MRNAワクチン)、用途別市場規模(感染症、がん、その他)、北米市場、アジア市場、中南米市場、中東・アフリカ市場分析、関連企業情報、サプライチェーン、販売チャネル分析、地域別市場規模予測データなどを掲載しています。
・レポート概要
・グローバル市場動向
・メーカー別競争状況
・mRNAワクチン&治療薬の種類別市場2015-2026:がん治療標準化MRNAワクチン、個別がん治療MRNAワクチン、感染症治療MRNAワクチン、感染予防MRNAワクチン
・mRNAワクチン&治療薬の用途別市場2015-2026:感染症、がん、その他
・mRNAワクチン&治療薬の北米市場分析
・mRNAワクチン&治療薬のアジア市場分析
・mRNAワクチン&治療薬の中南米市場分析
・mRNAワクチン&治療薬の中東・アフリカ市場分析
・関連企業情報:Moderna Therapeutics、CureVac、Translate Bio、BioNTech、Sangamo Therapeutics、Argos Therapeutics、In-Cell-Art、eTheRNA、Ethris、Tiba Biotechnology
・サプライチェーン及び販売チャネル分析
・地域別市場規模予測2021-2026:北米、ヨーロッパ、アジア、中南米、中東・アフリカ
・結論

mRNA is a rather versatile technology and offers a number of advantages. mRNA lacks genomic integration and its use results in transient expression of the encoded protein. This favorable safety profile makes mRNA especially attractive for vaccines and gene editing. mRNA is well defined chemically which ensures reproducible manufacturing at high yield, purity and activity. Improvements of lipid nanoparticle formulations as a vehicle for in vivo systemic delivery of mRNA has greatly favored the development of in vivo transfection strategies.
mRNA Cancer Vaccines and Therapeutics is in the development stage and there is no use in the market. The fastest research is Clinical phrase II, such as AGS-004 of Argos Therapeutics, SB-FIX, SB-318, SB-913 of Sangamo Therapeutics. The major application of mRNA Cancer Vaccines and Therapeutics is for infectious disease, cancer and others. And infectious disease and cancer are the major applications. The research of mRNA Cancer Vaccines and Therapeutics to treat infectious disease, cancer and others. The expenses on infectious disease is the most, with the market share of 45.7% in 2018.
In 2019, the global mRNA Vaccines & Therapeutics market size was US$ 1176.3 million and is forecast to US$ 2122.8 million in 2026, growing at a CAGR of 8.7% from 2020. In this study, 2019 has been considered as the base year and 2020 to 2026 as the forecast period to estimate the market size for mRNA Vaccines & Therapeutics.
The market research report offered here is a very useful resource that can help manufacturers, stakeholders, decision-makers, and other market participants to become familiar with every factor impacting the growth of the global mRNA Vaccines & Therapeutics market. The analysts authoring the report have closely studied key strategies adopted by top players of the global mRNA Vaccines & Therapeutics market. The report includes SWOT, and other market analyses to provide a clear and deep understanding of important aspects of the global mRNA Vaccines & Therapeutics market. Readers of the report can become informed about current and future trends of the global mRNA Vaccines & Therapeutics market and how they will impact market growth during the forecast period.
Geographic Segmentation
The report offers exhaustive assessment of different region-wise and country-wise mRNA Vaccines & Therapeutics markets such as U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E etc.
For the period 2015-2026, the report provides country-wise revenue and volume sales analysis and region-wise revenue and volume analysis of the global mRNA Vaccines & Therapeutics market. For the period 2015-2020, it provides sales (consumption) analysis and forecast of different regional markets by Application as well as by Type in terms of volume.
Market Segmentation by Type and by Application
The report includes a detailed analysis of leading and by Type and by Application segments of the global mRNA Vaccines & Therapeutics market. All of the segments covered in the report are broadly analyzed based on some deciding factors. The segmental analysis section of the report offers revenue, sales analysis and forecast of the global mRNA Vaccines & Therapeutics market by Type and by Application segment for the period 2015-2026.

Market Segment by Type, the mRNA Vaccines & Therapeutics market is segmented into
Standardization Of Cancer Treatment MRNA Vaccine
Individualized Cancer Treatment MRNA Vaccine
Infectious Disease Treatment MRNA Vaccine
Infection Prevention MRNA Vaccine

Market Segment by Application, the mRNA Vaccines & Therapeutics market is segmented into
Infectious Disease
Cancer
Other

This report includes the following manufacturers; we can also add the other companies as you want.
Moderna Therapeutics
CureVac
Translate Bio
BioNTech
Sangamo Therapeutics
Argos Therapeutics
In-Cell-Art
eTheRNA
Ethris
Tiba Biotechnology

The study objectives are:
To analyze and research the global mRNA Vaccines & Therapeutics status and future forecast, involving capacity, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
To present the key mRNA Vaccines & Therapeutics manufacturers, capacity, production, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications.
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of mRNA Vaccines & Therapeutics are as follows:
History Year: 2015-2020
Base Year: 2019
Estimated Year: 2020
Forecast Year 2020 to 2026

レポート目次

Table of Contents

1 Report Overview
1.1 Research Scope
1.2 Top mRNA Vaccines & Therapeutics Manufacturers Covered: Ranking by Revenue
1.3 Market Segment by Type
1.3.1 Global mRNA Vaccines & Therapeutics Market Size by Type: 2015 VS 2020 VS 2026 (US$ Million)
1.3.2 Standardization Of Cancer Treatment MRNA Vaccine
1.3.3 Individualized Cancer Treatment MRNA Vaccine
1.3.4 Infectious Disease Treatment MRNA Vaccine
1.3.5 Infection Prevention MRNA Vaccine
1.4 Market Segment by Application
1.4.1 Global mRNA Vaccines & Therapeutics Consumption by Application: 2015 VS 2020 VS 2026
1.4.2 Infectious Disease
1.4.3 Cancer
1.4.4 Other
1.5 Study Objectives
1.6 Years Considered
2 Global Market Perspective
2.1 Global mRNA Vaccines & Therapeutics Revenue (2015-2026)
2.1.1 Global mRNA Vaccines & Therapeutics Revenue (2015-2026)
2.1.2 Global mRNA Vaccines & Therapeutics Sales (2015-2026)
2.2 mRNA Vaccines & Therapeutics Market Size across Key Geographies Worldwide: 2015 VS 2020 VS 2026
2.2.1 Global mRNA Vaccines & Therapeutics Sales by Regions (2015-2020)
2.2.2 Global mRNA Vaccines & Therapeutics Revenue by Regions (2015-2020)
2.3 Global Top mRNA Vaccines & Therapeutics Regions (Countries) Ranking by Market Size
2.4 mRNA Vaccines & Therapeutics Industry Trends
2.4.1 mRNA Vaccines & Therapeutics Market Top Trends
2.4.2 Market Drivers
2.4.3 mRNA Vaccines & Therapeutics Market Challenges
2.4.4 Porter’s Five Forces Analysis
2.4.5 Primary Interviews with Key mRNA Vaccines & Therapeutics Players: Views for Future

3 Competitive Landscape by Manufacturers
3.1 Global Top mRNA Vaccines & Therapeutics Manufacturers by Sales (2015-2020)
3.1.1 Global mRNA Vaccines & Therapeutics Sales by Manufacturers (2015-2020)
3.1.2 Global mRNA Vaccines & Therapeutics Sales Market Share by Manufacturers (2015-2020)
3.1.3 Global 5 and 10 Largest Manufacturers by mRNA Vaccines & Therapeutics Sales in 2019
3.2 Global Top Manufacturers mRNA Vaccines & Therapeutics by Revenue
3.2.1 Global mRNA Vaccines & Therapeutics Revenue by Manufacturers (2015-2020)
3.2.2 Global mRNA Vaccines & Therapeutics Revenue Share by Manufacturers (2015-2020)
3.2.3 Global mRNA Vaccines & Therapeutics Market Concentration Ratio (CR5 and HHI)
3.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in mRNA Vaccines & Therapeutics as of 2019)
3.4 Global mRNA Vaccines & Therapeutics Average Selling Price (ASP) by Manufacturers
3.5 Key Manufacturers mRNA Vaccines & Therapeutics Plants/Factories Distribution and Area Served
3.6 Date of Key Manufacturers Enter into mRNA Vaccines & Therapeutics Market
3.7 Key Manufacturers mRNA Vaccines & Therapeutics Product Offered
3.8 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type
4.1 Global mRNA Vaccines & Therapeutics Historic Market Review by Type (2015-2020)
4.1.2 Global mRNA Vaccines & Therapeutics Sales Market Share by Type (2015-2020)
4.1.3 Global mRNA Vaccines & Therapeutics Revenue Market Share by Type (2015-2020)
4.1.4 mRNA Vaccines & Therapeutics Price by Type (2015-2020)
4.1 Global mRNA Vaccines & Therapeutics Market Estimates and Forecasts by Type (2021-2026)
4.2.2 Global mRNA Vaccines & Therapeutics Sales Forecast by Type (2021-2026)
4.2.3 Global mRNA Vaccines & Therapeutics Revenue Forecast by Type (2021-2026)
4.2.4 mRNA Vaccines & Therapeutics Price Forecast by Type (2021-2026)

5 Global mRNA Vaccines & Therapeutics Market Size by Application
5.1 Global mRNA Vaccines & Therapeutics Historic Market Review by Application (2015-2020)
5.1.2 Global mRNA Vaccines & Therapeutics Sales Market Share by Application (2015-2020)
5.1.3 Global mRNA Vaccines & Therapeutics Revenue Market Share by Application (2015-2020)
5.1.4 mRNA Vaccines & Therapeutics Price by Application (2015-2020)
5.2 Global mRNA Vaccines & Therapeutics Market Estimates and Forecasts by Application (2021-2026)
5.2.2 Global mRNA Vaccines & Therapeutics Sales Forecast by Application (2021-2026)
5.2.3 Global mRNA Vaccines & Therapeutics Revenue Forecast by Application (2021-2026)
5.2.4 mRNA Vaccines & Therapeutics Price Forecast by Application (2021-2026)

6 North America
6.1 North America mRNA Vaccines & Therapeutics Breakdown Data by Company
6.2 North America mRNA Vaccines & Therapeutics Breakdown Data by Type
6.3 North America mRNA Vaccines & Therapeutics Breakdown Data by Application
6.4 North America mRNA Vaccines & Therapeutics Breakdown Data by Countries
6.4.1 North America mRNA Vaccines & Therapeutics Sales by Countries
6.4.2 North America mRNA Vaccines & Therapeutics Revenue by Countries
6.4.3 U.S.
6.4.4 Canada

7 Europe
7.1 Europe mRNA Vaccines & Therapeutics Breakdown Data by Company
7.2 Europe mRNA Vaccines & Therapeutics Breakdown Data by Type
7.3 Europe mRNA Vaccines & Therapeutics Breakdown Data by Application
7.4 Europe mRNA Vaccines & Therapeutics Breakdown Data by Countries
7.4.1 Europe mRNA Vaccines & Therapeutics Sales by Countries
7.4.2 Europe mRNA Vaccines & Therapeutics Revenue by Countries
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia

8 Asia Pacific
8.1 Asia Pacific mRNA Vaccines & Therapeutics Breakdown Data by Company
8.2 Asia Pacific mRNA Vaccines & Therapeutics Breakdown Data by Type
8.3 Asia Pacific mRNA Vaccines & Therapeutics Breakdown Data by Application
8.4 Asia Pacific mRNA Vaccines & Therapeutics Breakdown Data by Regions
8.4.1 Asia Pacific mRNA Vaccines & Therapeutics Sales by Regions
8.4.2 Asia Pacific mRNA Vaccines & Therapeutics Revenue by Regions
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 India
8.4.7 Australia
8.4.8 Taiwan
8.4.9 Indonesia
8.4.10 Thailand
8.4.11 Malaysia
8.4.12 Philippines
8.4.13 Vietnam

9 Latin America
9.1 Latin America mRNA Vaccines & Therapeutics Breakdown Data by Company
9.2 Latin America mRNA Vaccines & Therapeutics Breakdown Data by Type
9.3 Latin America mRNA Vaccines & Therapeutics Breakdown Data by Application
9.4 Latin America mRNA Vaccines & Therapeutics Breakdown Data by Countries
9.4.1 Latin America mRNA Vaccines & Therapeutics Sales by Countries
9.4.2 Latin America mRNA Vaccines & Therapeutics Revenue by Countries
9.4.3 Mexico
9.4.4 Brazil
9.4.5 Argentina

10 Middle East and Africa
10.1 Middle East and Africa mRNA Vaccines & Therapeutics Breakdown Data by Type
10.2 Middle East and Africa mRNA Vaccines & Therapeutics Breakdown Data by Application
10.3 Middle East and Africa mRNA Vaccines & Therapeutics Breakdown Data by Countries
10.3.1 Middle East and Africa mRNA Vaccines & Therapeutics Sales by Countries
10.3.2 Middle East and Africa mRNA Vaccines & Therapeutics Revenue by Countries
10.3.3 Turkey
10.3.4 Saudi Arabia
10.3.5 U.A.E

11 Company Profiles
11.1 Moderna Therapeutics
11.1.1 Moderna Therapeutics Corporation Information
11.1.2 Moderna Therapeutics Business Overview and Total Revenue (2019 VS 2018)
11.1.3 Moderna Therapeutics mRNA Vaccines & Therapeutics Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.1.4 Moderna Therapeutics mRNA Vaccines & Therapeutics Products and Services
11.1.5 Moderna Therapeutics SWOT Analysis
11.1.6 Moderna Therapeutics Recent Developments
11.2 CureVac
11.2.1 CureVac Corporation Information
11.2.2 CureVac Business Overview and Total Revenue (2019 VS 2018)
11.2.3 CureVac mRNA Vaccines & Therapeutics Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.2.4 CureVac mRNA Vaccines & Therapeutics Products and Services
11.2.5 CureVac SWOT Analysis
11.2.6 CureVac Recent Developments
11.3 Translate Bio
11.3.1 Translate Bio Corporation Information
11.3.2 Translate Bio Business Overview and Total Revenue (2019 VS 2018)
11.3.3 Translate Bio mRNA Vaccines & Therapeutics Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.3.4 Translate Bio mRNA Vaccines & Therapeutics Products and Services
11.3.5 Translate Bio SWOT Analysis
11.3.6 Translate Bio Recent Developments
11.4 BioNTech
11.4.1 BioNTech Corporation Information
11.4.2 BioNTech Business Overview and Total Revenue (2019 VS 2018)
11.4.3 BioNTech mRNA Vaccines & Therapeutics Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.4.4 BioNTech mRNA Vaccines & Therapeutics Products and Services
11.4.5 BioNTech SWOT Analysis
11.4.6 BioNTech Recent Developments
11.5 Sangamo Therapeutics
11.5.1 Sangamo Therapeutics Corporation Information
11.5.2 Sangamo Therapeutics Business Overview and Total Revenue (2019 VS 2018)
11.5.3 Sangamo Therapeutics mRNA Vaccines & Therapeutics Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.5.4 Sangamo Therapeutics mRNA Vaccines & Therapeutics Products and Services
11.5.5 Sangamo Therapeutics SWOT Analysis
11.5.6 Sangamo Therapeutics Recent Developments
11.6 Argos Therapeutics
11.6.1 Argos Therapeutics Corporation Information
11.6.2 Argos Therapeutics Business Overview and Total Revenue (2019 VS 2018)
11.6.3 Argos Therapeutics mRNA Vaccines & Therapeutics Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.6.4 Argos Therapeutics mRNA Vaccines & Therapeutics Products and Services
11.6.5 Argos Therapeutics SWOT Analysis
11.6.6 Argos Therapeutics Recent Developments
11.7 In-Cell-Art
11.7.1 In-Cell-Art Corporation Information
11.7.2 In-Cell-Art Business Overview and Total Revenue (2019 VS 2018)
11.7.3 In-Cell-Art mRNA Vaccines & Therapeutics Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.7.4 In-Cell-Art mRNA Vaccines & Therapeutics Products and Services
11.7.5 In-Cell-Art SWOT Analysis
11.7.6 In-Cell-Art Recent Developments
11.8 eTheRNA
11.8.1 eTheRNA Corporation Information
11.8.2 eTheRNA Business Overview and Total Revenue (2019 VS 2018)
11.8.3 eTheRNA mRNA Vaccines & Therapeutics Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.8.4 eTheRNA mRNA Vaccines & Therapeutics Products and Services
11.8.5 eTheRNA SWOT Analysis
11.8.6 eTheRNA Recent Developments
11.9 Ethris
11.9.1 Ethris Corporation Information
11.9.2 Ethris Business Overview and Total Revenue (2019 VS 2018)
11.9.3 Ethris mRNA Vaccines & Therapeutics Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.9.4 Ethris mRNA Vaccines & Therapeutics Products and Services
11.9.5 Ethris SWOT Analysis
11.9.6 Ethris Recent Developments
11.10 Tiba Biotechnology
11.10.1 Tiba Biotechnology Corporation Information
11.10.2 Tiba Biotechnology Business Overview and Total Revenue (2019 VS 2018)
11.10.3 Tiba Biotechnology mRNA Vaccines & Therapeutics Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.10.4 Tiba Biotechnology mRNA Vaccines & Therapeutics Products and Services
11.10.5 Tiba Biotechnology SWOT Analysis
11.10.6 Tiba Biotechnology Recent Developments

12 Supply Chain and Sales Channels Analysis
12.1 Supply Chain Analysis
12.2 Sales Channels Analysis
12.2.1 mRNA Vaccines & Therapeutics Sales Channels
12.2.2 mRNA Vaccines & Therapeutics Distributors
12.3 mRNA Vaccines & Therapeutics Customers

13 Estimates and Projections by Regions (2021-2026)
13.1 Global mRNA Vaccines & Therapeutics Sales Forecast (2021-2026)
13.1.1 Global mRNA Vaccines & Therapeutics Sales Forecast by Regions (2021-2026)
13.1.2 Global mRNA Vaccines & Therapeutics Revenue Forecast by Regions (2021-2026)
13.2 North America Market Size Forecast (2021-2026)
13.2.1 North America mRNA Vaccines & Therapeutics Sales Forecast (2021-2026)
13.2.2 North America mRNA Vaccines & Therapeutics Revenue Forecast (2021-2026)
13.2.3 North America mRNA Vaccines & Therapeutics Size Forecast by County (2021-2026)
13.3 Europe Market Size Forecast (2021-2026)
13.3.1 Europe mRNA Vaccines & Therapeutics Sales Forecast (2021-2026)
13.3.2 Europe mRNA Vaccines & Therapeutics Revenue Forecast (2021-2026)
13.3.3 Europe mRNA Vaccines & Therapeutics Size Forecast by County (2021-2026)
13.4 Asia Pacific Market Size Forecast (2021-2026)
13.4.1 Asia Pacific mRNA Vaccines & Therapeutics Sales Forecast (2021-2026)
13.4.2 Asia Pacific mRNA Vaccines & Therapeutics Revenue Forecast (2021-2026)
13.4.3 Asia Pacific mRNA Vaccines & Therapeutics Size Forecast by Region (2021-2026)
13.5 Latin America Market Size Forecast (2021-2026)
13.5.1 Latin America mRNA Vaccines & Therapeutics Sales Forecast (2021-2026)
13.5.2 Latin America mRNA Vaccines & Therapeutics Revenue Forecast (2021-2026)
13.5.3 Latin America mRNA Vaccines & Therapeutics Size Forecast by County (2021-2026)
13.6 Middle East and Africa Market Forecast
13.6.1 Middle East and Africa mRNA Vaccines & Therapeutics Sales Forecast (2021-2026)
13.6.2 Middle East and Africa mRNA Vaccines & Therapeutics Revenue Forecast (2021-2026)
13.6.3 Middle East and Africa mRNA Vaccines & Therapeutics Size Forecast by County (2021-2026)

14 Research Findings and Conclusion

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Tables
Table 1. mRNA Vaccines & Therapeutics Key Market Segments
Table 2. Ranking of Global Top mRNA Vaccines & Therapeutics Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global mRNA Vaccines & Therapeutics Market Size Growth Rate by Type 2021-2026 (K Units) & (Million US$)
Table 4. Major Manufacturers of Standardization Of Cancer Treatment MRNA Vaccine
Table 5. Major Manufacturers of Individualized Cancer Treatment MRNA Vaccine
Table 6. Major Manufacturers of Infectious Disease Treatment MRNA Vaccine
Table 7. Major Manufacturers of Infection Prevention MRNA Vaccine
Table 8. Global mRNA Vaccines & Therapeutics Market Share by Application 2019-2025 (K Units)
Table 9. Global mRNA Vaccines & Therapeutics Market Size by Regions 2015-2020 (K Units) & (Million US$)
Table 10. Global mRNA Vaccines & Therapeutics Sales by Regions 2015-2020 (K Units)
Table 11. Global mRNA Vaccines & Therapeutics Sales Market Share by Regions 2015-2020
Table 12. Global mRNA Vaccines & Therapeutics Revenue by Regions 2015-2020 (Million US$)
Table 13. Global mRNA Vaccines & Therapeutics Revenue Market Share by Regions 2015-2020
Table 14. Top mRNA Vaccines & Therapeutics Regions (Countries) Ranking by Market Size (US$ Million) in 2019
Table 15. Market Top Trends
Table 16. mRNA Vaccines & Therapeutics Key Drivers: Impact Analysis (2021-2026)
Table 17. mRNA Vaccines & Therapeutics Key Challenges
Table 18. Main Points Interviewed from Key mRNA Vaccines & Therapeutics Players: Views for Future
Table 19. Global mRNA Vaccines & Therapeutics Sales by Manufacturers (2015-2020) (K Units)
Table 20. Global mRNA Vaccines & Therapeutics Sales Share by Manufacturers (2015-2020)
Table 21. mRNA Vaccines & Therapeutics Revenue by Manufacturers (2015-2020) (Million US$)
Table 22. mRNA Vaccines & Therapeutics Revenue Share by Manufacturers (2015-2020)
Table 23. Global mRNA Vaccines & Therapeutics Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 24. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in mRNA Vaccines & Therapeutics as of 2019)
Table 25. Key Manufacturers mRNA Vaccines & Therapeutics Average Selling Price (ASP) (2015-2020) (USD/Unit)
Table 26. Key Manufacturers mRNA Vaccines & Therapeutics Plants/Factories Distribution
Table 27. Key Manufacturers mRNA Vaccines & Therapeutics Area Served
Table 28. Date of Key Manufacturers Enter into mRNA Vaccines & Therapeutics Market
Table 29. Key Manufacturers mRNA Vaccines & Therapeutics Product Type
Table 30. Mergers & Acquisitions, Expansion Plans
Table 31. Global Standardization Of Cancer Treatment MRNA Vaccine Sales and Revenue (2015-2020) (K Units) & (Million US$)
Table 32. Global Individualized Cancer Treatment MRNA Vaccine Sales and Revenue (2015-2020) (K Units) & (Million US$)
Table 33. Global Infectious Disease Treatment MRNA Vaccine Sales ana Revenue (2015-2020) (K Units) & (Million US$)
Table 34. Global Infection Prevention MRNA Vaccine Sales ana Revenue (2015-2020) (K Units) & (Million US$)
Table 35. Global mRNA Vaccines & Therapeutics Sales (K Units) by Type (2015-2020)
Table 36. Global mRNA Vaccines & Therapeutics Sales Share by Type (2015-2020)
Table 37. Global mRNA Vaccines & Therapeutics Revenue (US$ Million) Market Share by Type (2015-2020)
Table 38. Global mRNA Vaccines & Therapeutics Price (K Units) by Type (2015-2020)
Table 39. Global mRNA Vaccines & Therapeutics Sales (K Units) by Type (2021-2026)
Table 40. Global mRNA Vaccines & Therapeutics Sales Share by Type (2021-2026)
Table 41. Global mRNA Vaccines & Therapeutics Revenue (US$ Million) Market Share by Type (2021-2026)
Table 42. Global mRNA Vaccines & Therapeutics Revenue Share by Type (2021-2026)
Table 43. Global mRNA Vaccines & Therapeutics Price (K Units) by Type (2021-2026)
Table 44. Global mRNA Vaccines & Therapeutics Sales (K Units) by Application (2015-2020)
Table 45. Global mRNA Vaccines & Therapeutics Sales Share by Application (2015-2020)
Table 46. Global mRNA Vaccines & Therapeutics Revenue (US$ Million) Market Share by Application (2015-2020)
Table 47. Global mRNA Vaccines & Therapeutics Price by Application 2015-2020 (USD/Unit)
Table 48. Global mRNA Vaccines & Therapeutics Sales by Application (2015-2020) (K Units)
Table 49. Global mRNA Vaccines & Therapeutics Sales Share by Application (2015-2020)
Table 50. Global mRNA Vaccines & Therapeutics Revenue (US$ Million) Market Share by Application (2021-2026)
Table 51. Global mRNA Vaccines & Therapeutics Revenue Share by Application (2021-2026)
Table 52. Global mRNA Vaccines & Therapeutics Price (K Units) by Application (2021-2026)
Table 53. North America mRNA Vaccines & Therapeutics Sales by Company (2015-2020) (K Units)
Table 54. North America mRNA Vaccines & Therapeutics Sales Market Share by Company (2015-2020)
Table 55. North America mRNA Vaccines & Therapeutics Sales by Type (2015-2020) (K Units)
Table 56. North America mRNA Vaccines & Therapeutics Sales Market Share by Type (2015-2020)
Table 57. North America mRNA Vaccines & Therapeutics Sales by Application (2015-2020) (K Units)
Table 58. North America mRNA Vaccines & Therapeutics Sales Market Share by Application (2015-2020)
Table 59. North America mRNA Vaccines & Therapeutics Sales by Countries (2015-2020) (K Units)
Table 60. North America mRNA Vaccines & Therapeutics Sales Market Share by Countries (2015-2020)
Table 61. North America mRNA Vaccines & Therapeutics Revenue by Countries (2015-2020) (Million US$)
Table 62. North America mRNA Vaccines & Therapeutics Revenue Market Share by Countries (2015-2020)
Table 63. Europe mRNA Vaccines & Therapeutics Sales by Company (2015-2020) (K Units)
Table 64. Europe mRNA Vaccines & Therapeutics Sales Market Share by Company (2015-2020)
Table 65. Europe mRNA Vaccines & Therapeutics Sales by Type (2015-2020) (K Units)
Table 66. Europe mRNA Vaccines & Therapeutics Sales Market Share by Type (2015-2020)
Table 67. Europe mRNA Vaccines & Therapeutics Sales by Application (2015-2020) (K Units)
Table 68. Europe mRNA Vaccines & Therapeutics Sales Market Share by Application (2015-2020)
Table 69. Europe mRNA Vaccines & Therapeutics Sales by Countries (2015-2020) (K Units)
Table 70. Europe mRNA Vaccines & Therapeutics Sales Market Share by Countries (2015-2020)
Table 71. Europe mRNA Vaccines & Therapeutics Revenue by Countries (2015-2020) (Million US$)
Table 72. Europe mRNA Vaccines & Therapeutics Revenue Market Share by Countries (2015-2020)
Table 73. Asia Pacific mRNA Vaccines & Therapeutics Sales by Regions (2015-2020) (K Units)
Table 74. Asia Pacific mRNA Vaccines & Therapeutics Sales Market Share by Regions (2015-2020)
Table 75. Asia Pacific mRNA Vaccines & Therapeutics Sales by Type (2015-2020) (K Units)
Table 76. Asia Pacific mRNA Vaccines & Therapeutics Sales Market Share by Type (2015-2020)
Table 77. Asia Pacific mRNA Vaccines & Therapeutics Sales by Application (2015-2020) (K Units)
Table 78. Asia Pacific mRNA Vaccines & Therapeutics Sales Market Share by Application (2015-2020)
Table 79. Asia Pacific mRNA Vaccines & Therapeutics Sales by Countries (2015-2020) (K Units)
Table 80. Asia Pacific mRNA Vaccines & Therapeutics Sales Market Share by Regions (2015-2020)
Table 81. Asia Pacific mRNA Vaccines & Therapeutics Revenue by Regions (2015-2020) (Million US$)
Table 82. Asia Pacific mRNA Vaccines & Therapeutics Revenue Market Share by Regions (2015-2020)
Table 83. Latin America mRNA Vaccines & Therapeutics Sales by Company (2015-2020) (K Units)
Table 84. Latin America mRNA Vaccines & Therapeutics Sales Market Share by Company (2015-2020)
Table 85. Latin America mRNA Vaccines & Therapeutics Sales by Type (2015-2020) (K Units)
Table 86. Latin America mRNA Vaccines & Therapeutics Sales Market Share by Type (2015-2020)
Table 87. Latin America mRNA Vaccines & Therapeutics Sales by Application (2015-2020) (K Units)
Table 88. Latin America mRNA Vaccines & Therapeutics Sales Market Share by Application (2015-2020)
Table 89. Latin America mRNA Vaccines & Therapeutics Sales by Countries (2015-2020) (K Units)
Table 90. Latin America mRNA Vaccines & Therapeutics Sales Market Share by Countries (2015-2020)
Table 91. Latin America mRNA Vaccines & Therapeutics Revenue by Countries (2015-2020) (Million US$)
Table 92. Latin America mRNA Vaccines & Therapeutics Revenue Market Share by Countries (2015-2020)
Table 93. Middle East and Africa mRNA Vaccines & Therapeutics Sales by Type (2015-2020) (K Units)
Table 94. Middle East and Africa mRNA Vaccines & Therapeutics Sales Market Share by Type (2015-2020)
Table 95. Middle East and Africa mRNA Vaccines & Therapeutics Sales by Application (2015-2020) (K Units)
Table 96. Middle East and Africa mRNA Vaccines & Therapeutics Sales Market Share by Application (2015-2020)
Table 97. Middle East and Africa mRNA Vaccines & Therapeutics Sales by Countries (2015-2020) (K Units)
Table 98. Middle East and Africa mRNA Vaccines & Therapeutics Sales Market Share by Countries (2015-2020)
Table 99. Middle East and Africa mRNA Vaccines & Therapeutics Revenue by Countries (2015-2020) (Million US$)
Table 100. Middle East and Africa mRNA Vaccines & Therapeutics Revenue Market Share by Countries (2015-2020)
Table 101. Moderna Therapeutics Company Details
Table 102. Moderna Therapeutics Description and Business Overview
Table 103. Moderna Therapeutics mRNA Vaccines & Therapeutics Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 104. Moderna Therapeutics mRNA Vaccines & Therapeutics Sales Growth Rate (2015-2020)
Table 105. Moderna Therapeutics mRNA Vaccines & Therapeutics Sales Market Share in Global Market
Table 106. Moderna Therapeutics Recent Development
Table 107. CureVac Company Details
Table 108. CureVac Description and Business Overview
Table 109. CureVac mRNA Vaccines & Therapeutics Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 110. CureVac mRNA Vaccines & Therapeutics Sales Growth Rate (2015-2020)
Table 111. CureVac mRNA Vaccines & Therapeutics Sales Market Share in Global Market
Table 112. CureVac Recent Development
Table 113. Translate Bio Company Details
Table 114. Translate Bio Description and Business Overview
Table 115. Translate Bio mRNA Vaccines & Therapeutics Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 116. Translate Bio mRNA Vaccines & Therapeutics Sales Growth Rate (2015-2020)
Table 117. Translate Bio mRNA Vaccines & Therapeutics Sales Market Share in Global Market
Table 118. Translate Bio Recent Development
Table 119. BioNTech Company Details
Table 120. BioNTech Description and Business Overview
Table 121. BioNTech mRNA Vaccines & Therapeutics Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 122. BioNTech mRNA Vaccines & Therapeutics Sales Growth Rate (2015-2020)
Table 123. BioNTech mRNA Vaccines & Therapeutics Sales Market Share in Global Market
Table 124. BioNTech Recent Development
Table 125. Sangamo Therapeutics Company Details
Table 126. Sangamo Therapeutics Description and Business Overview
Table 127. Sangamo Therapeutics mRNA Vaccines & Therapeutics Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 128. Sangamo Therapeutics mRNA Vaccines & Therapeutics Sales Growth Rate (2015-2020)
Table 129. Sangamo Therapeutics mRNA Vaccines & Therapeutics Sales Market Share in Global Market
Table 130. Sangamo Therapeutics Recent Development
Table 131. Argos Therapeutics Company Details
Table 132. Argos Therapeutics Description and Business Overview
Table 133. Argos Therapeutics mRNA Vaccines & Therapeutics Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 134. Argos Therapeutics mRNA Vaccines & Therapeutics Sales Growth Rate (2015-2020)
Table 135. Argos Therapeutics mRNA Vaccines & Therapeutics Sales Market Share in Global Market
Table 136. Argos Therapeutics Recent Development
Table 137. In-Cell-Art Company Details
Table 138. In-Cell-Art Description and Business Overview
Table 139. In-Cell-Art mRNA Vaccines & Therapeutics Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 140. In-Cell-Art mRNA Vaccines & Therapeutics Sales Growth Rate (2015-2020)
Table 141. In-Cell-Art mRNA Vaccines & Therapeutics Sales Market Share in Global Market
Table 142. In-Cell-Art Recent Development
Table 143. eTheRNA Company Details
Table 144. eTheRNA Description and Business Overview
Table 145. eTheRNA mRNA Vaccines & Therapeutics Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 146. eTheRNA mRNA Vaccines & Therapeutics Sales Growth Rate (2015-2020)
Table 147. eTheRNA mRNA Vaccines & Therapeutics Sales Market Share in Global Market
Table 148. eTheRNA Recent Development
Table 149. Ethris Company Details
Table 150. Ethris Description and Business Overview
Table 151. Ethris mRNA Vaccines & Therapeutics Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 152. Ethris mRNA Vaccines & Therapeutics Sales Growth Rate (2015-2020)
Table 153. Ethris mRNA Vaccines & Therapeutics Sales Market Share in Global Market
Table 154. Ethris Recent Development
Table 155. Tiba Biotechnology Company Details
Table 156. Tiba Biotechnology Description and Business Overview
Table 157. Tiba Biotechnology mRNA Vaccines & Therapeutics Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 158. Tiba Biotechnology mRNA Vaccines & Therapeutics Sales Growth Rate (2015-2020)
Table 159. Tiba Biotechnology mRNA Vaccines & Therapeutics Sales Market Share in Global Market
Table 160. Tiba Biotechnology Recent Development
Table 161. mRNA Vaccines & Therapeutics Distributors List
Table 162. mRNA Vaccines & Therapeutics Customers List
Table 163. Global mRNA Vaccines & Therapeutics Sales Forecast 2021-2026 (K Units) & (Million US$)
Table 164. Global mRNA Vaccines & Therapeutics Sales Forecast by Type 2021-2026 (K Units)
Table 165. Global mRNA Vaccines & Therapeutics Sales Forecast by Application 2021-2026 (K Units)
Table 166. Global mRNA Vaccines & Therapeutics Sales Forecast by Regions 2021-2026 (K Units)
Table 167. Global mRNA Vaccines & Therapeutics Revenue Forecast by Regions 2021-2026 (Million US$)
Table 168. North America mRNA Vaccines & Therapeutics Sales Forecast by Countries 2021-2026 (K Units)
Table 169. North America mRNA Vaccines & Therapeutics Revenue Forecast by Countries 2021-2026
Table 170. Europe mRNA Vaccines & Therapeutics Sales Forecast by Countries 2021-2026 (K Units)
Table 171. Europe mRNA Vaccines & Therapeutics Revenue Market Share Forecast by Countries 2021-2026
Table 172. Asia Pacific mRNA Vaccines & Therapeutics Sales Forecast by Regions 2021-2026 (K Units)
Table 173. Asia Pacific mRNA Vaccines & Therapeutics Revenue Forecast by Regions 2021-2026 (Million US$)
Table 174. Latin America mRNA Vaccines & Therapeutics Sales Forecast by Countries 2021-2026 (K Units)
Table 175. Latin America mRNA Vaccines & Therapeutics Revenue Forecast by Countries 2021-2026 (Million US$)
Table 176. Middle East and Africa mRNA Vaccines & Therapeutics Sales Forecast by Regions 2021-2026 (K Units)
Table 177. Middle East and Africa mRNA Vaccines & Therapeutics Revenue Forecast by Regions 2021-2026 (Million US$)
Table 178. Research Programs/Design for This Report
Table 179. Key Data Information from Secondary Sources
Table 180. Key Data Information from Primary Sources
List of Figures
Figure 1. mRNA Vaccines & Therapeutics Product Picture
Figure 2. Global mRNA Vaccines & Therapeutics Sales Market Shar by Type 2015-2026
Figure 3. Standardization Of Cancer Treatment MRNA Vaccine Figures
Figure 4. Individualized Cancer Treatment MRNA Vaccine Figures
Figure 5. Infectious Disease Treatment MRNA Vaccine Figures
Figure 6. Infection Prevention MRNA Vaccine Figures
Figure 7. Global mRNA Vaccines & Therapeutics Sales Market Share by Application in 2019 & 2026
Figure 8. Infectious Disease Use Case
Figure 9. Cancer Use Case
Figure 10. Other Use Case
Figure 11. mRNA Vaccines & Therapeutics Report Years Considered
Figure 12. Global mRNA Vaccines & Therapeutics Market Size 2015-2026 (Million US$)
Figure 13. Global mRNA Vaccines & Therapeutics Sales 2015-2020 (K Units)
Figure 14. Global mRNA Vaccines & Therapeutics Market Size Market Share by Regions 2015-2020
Figure 15. Global mRNA Vaccines & Therapeutics Sales Market Share by Regions in 2019
Figure 16. Porter's Five Forces Analysis
Figure 17. Global mRNA Vaccines & Therapeutics Sales Share by Manufacturers in 2019
Figure 18. The 5 and 10 Largest Manufacturers in the World: Market Share by mRNA Vaccines & Therapeutics Sales in 2019
Figure 19. mRNA Vaccines & Therapeutics Value Share by Manufacturers in 2019
Figure 20. mRNA Vaccines & Therapeutics Revenue Share by Manufacturers In 2019
Figure 21. mRNA Vaccines & Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 22. Global mRNA Vaccines & Therapeutics Revenue Share by Type (2015-2020)
Figure 23. Global mRNA Vaccines & Therapeutics Revenue Growth Rate by Type in 2015 & 2019
Figure 24. Global mRNA Vaccines & Therapeutics Market Share by Price Range (2015-2020)
Figure 25. Global mRNA Vaccines & Therapeutics Revenue Share by Application (2015-2020)
Figure 26. Global mRNA Vaccines & Therapeutics Revenue Growth Rate by Application in 2015 & 2019
Figure 27. North America mRNA Vaccines & Therapeutics Revenue Growth Rate 2015-2020 (Million US$)
Figure 28. U.S. mRNA Vaccines & Therapeutics Sales Growth Rate (2015-2020) (K Units)
Figure 29. Canada mRNA Vaccines & Therapeutics Sales Growth Rate (2015-2020) (K Units)
Figure 30. Europe mRNA Vaccines & Therapeutics Revenue Growth Rate 2015-2020 (Million US$)
Figure 31. Germany mRNA Vaccines & Therapeutics Sales Growth Rate (2015-2020) (K Units)
Figure 32. France mRNA Vaccines & Therapeutics Sales Growth Rate (2015-2020) (K Units)
Figure 33. U.K. mRNA Vaccines & Therapeutics Sales Growth Rate (2015-2020) (K Units)
Figure 34. Italy mRNA Vaccines & Therapeutics Sales Growth Rate (2015-2020) (K Units)
Figure 35. Russia mRNA Vaccines & Therapeutics Sales Growth Rate (2015-2020) (K Units)
Figure 36. Asia Pacific mRNA Vaccines & Therapeutics Revenue Growth Rate 2015-2020 (Million US$)
Figure 37. China mRNA Vaccines & Therapeutics Sales Growth Rate (2015-2020) (K Units)
Figure 38. Japan mRNA Vaccines & Therapeutics Sales Growth Rate (2015-2020) (K Units)
Figure 39. South Korea mRNA Vaccines & Therapeutics Sales Growth Rate (2015-2020) (K Units)
Figure 40. India mRNA Vaccines & Therapeutics Sales Growth Rate (2015-2020) (K Units)
Figure 41. Australia mRNA Vaccines & Therapeutics Sales Growth Rate (2015-2020) (K Units)
Figure 42. Taiwan mRNA Vaccines & Therapeutics Sales Growth Rate (2015-2020) (K Units)
Figure 43. Indonesia mRNA Vaccines & Therapeutics Sales Growth Rate (2015-2020) (K Units)
Figure 44. Thailand mRNA Vaccines & Therapeutics Sales Growth Rate (2015-2020) (K Units)
Figure 45. Malaysia mRNA Vaccines & Therapeutics Sales Growth Rate (2015-2020) (K Units)
Figure 46. Philippines mRNA Vaccines & Therapeutics Sales Growth Rate (2015-2020) (K Units)
Figure 47. Vietnam mRNA Vaccines & Therapeutics Sales Growth Rate (2015-2020) (K Units)
Figure 48. Latin America mRNA Vaccines & Therapeutics Revenue Growth Rate 2015-2020 (Million US$)
Figure 49. Mexico mRNA Vaccines & Therapeutics Sales Growth Rate (2015-2020) (K Units)
Figure 50. Brazil mRNA Vaccines & Therapeutics Sales Growth Rate (2015-2020) (K Units)
Figure 51. Argentina mRNA Vaccines & Therapeutics Sales Growth Rate (2015-2020) (K Units)
Figure 52. Middle East and Africa mRNA Vaccines & Therapeutics Revenue Growth Rate 2015-2020 (Million US$)
Figure 53. Turkey mRNA Vaccines & Therapeutics Sales Growth Rate (2015-2020) (K Units)
Figure 54. Saudi Arabia mRNA Vaccines & Therapeutics Sales Growth Rate (2015-2020) (K Units)
Figure 55. U.A.E mRNA Vaccines & Therapeutics Sales Growth Rate (2015-2020) (K Units)
Figure 56. Moderna Therapeutics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 57. CureVac Total Revenue (US$ Million): 2019 Compared with 2018
Figure 58. Translate Bio Total Revenue (US$ Million): 2019 Compared with 2018
Figure 59. BioNTech Total Revenue (US$ Million): 2019 Compared with 2018
Figure 60. Sangamo Therapeutics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 61. Argos Therapeutics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 62. In-Cell-Art Total Revenue (US$ Million): 2019 Compared with 2018
Figure 63. eTheRNA Total Revenue (US$ Million): 2019 Compared with 2018
Figure 64. Ethris Total Revenue (US$ Million): 2019 Compared with 2018
Figure 65. Tiba Biotechnology Total Revenue (US$ Million): 2019 Compared with 2018
Figure 66. mRNA Vaccines & Therapeutics Value Chain
Figure 67. Channels of Distribution
Figure 68. Distributors Profiles
Figure 69. North America mRNA Vaccines & Therapeutics Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 70. North America mRNA Vaccines & Therapeutics Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 71. Europe mRNA Vaccines & Therapeutics Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 72. Europe mRNA Vaccines & Therapeutics Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 73. Asia Pacific mRNA Vaccines & Therapeutics Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 74. Asia Pacific mRNA Vaccines & Therapeutics Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 75. Latin America mRNA Vaccines & Therapeutics Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 76. Latin America mRNA Vaccines & Therapeutics Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 77. Middle East and Africa mRNA Vaccines & Therapeutics Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 78. Middle East and Africa mRNA Vaccines & Therapeutics Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 79. Bottom-up and Top-down Approaches for This Report
Figure 80. Data Triangulation
Figure 81. Key Executives Interviewed